trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Melanoma D008545 69 associated lipids
Medulloblastoma D008527 22 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Lung Neoplasms D008175 171 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Wu Y et al. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. 2007 Reprod Sci pmid:17644810
Hishiki T et al. BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3. 2007 J. Biol. Chem. pmid:17644518
Kotake Y et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide. 2007 Nat. Chem. Biol. pmid:17643112
Kaida D et al. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. 2007 Nat. Chem. Biol. pmid:17643111
Dai B and Rasmussen TP Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. 2007 Stem Cells pmid:17641388
Imai N et al. Inhibition of histone deacetylase activates side population cells in kidney and partially reverses chronic renal injury. 2007 Stem Cells pmid:17641247
Bode KA et al. Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment. 2007 Immunology pmid:17635610
Schneider G et al. HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2. 2007 Cell Prolif. pmid:17635519
Ho AK et al. Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytes. 2007 Endocrinology pmid:17628002
Strobl JS et al. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. 2007 J. Parasitol. pmid:17626366
Zampetaki A et al. Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-alpha is rescued by HDAC inhibitor trichostatin A. 2007 Am. J. Physiol., Cell Physiol. pmid:17626239
Dombrowsky H and Uhlig S Steroids and histone deacetylase in ventilation-induced gene transcription. 2007 Eur. Respir. J. pmid:17626110
Bu Y and Gelman IH v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex. 2007 J. Biol. Chem. pmid:17626016
Kato N et al. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. 2007 Leukemia pmid:17625602
Loudni L et al. Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17624773
Zhao Y et al. Roles of histone acetylation modification in basal and inducible expression of hsp26 gene in D. melanogaster. 2007 Mol. Cell. Biochem. pmid:17619947
Perales M and Más P A functional link between rhythmic changes in chromatin structure and the Arabidopsis biological clock. 2007 Plant Cell pmid:17616736
Shi J et al. Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. 2007 Cancer Res. pmid:17616702
Zhang X et al. Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression. 2007 Biochem. Cell Biol. pmid:17612628
Platta CS et al. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. 2007 J. Surg. Res. pmid:17612559
Ehrenkaufer GM et al. Trichostatin A effects on gene expression in the protozoan parasite Entamoeba histolytica. 2007 BMC Genomics pmid:17612405
Glenisson W et al. Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation. 2007 Biochim. Biophys. Acta pmid:17610967
Chen B and Cepko CL Requirement of histone deacetylase activity for the expression of critical photoreceptor genes. 2007 BMC Dev. Biol. pmid:17603891
Subramanian C et al. CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. 2007 Neoplasia pmid:17603632
Kang JH et al. Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1. 2007 Exp. Mol. Med. pmid:17603295
Mogal AP et al. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation. 2007 J. Biol. Chem. pmid:17602165
Tuncel M et al. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. 2007 Cancer Biother. Radiopharm. pmid:17600477
Ye J et al. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. 2007 J. Virol. pmid:17596302
Castro-Galache MD et al. Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells. 2007 Int. J. Biochem. Cell Biol. pmid:17588800
Lee S et al. Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17588744
Huang JC et al. Changes in histone acetylation during postovulatory aging of mouse oocyte. 2007 Biol. Reprod. pmid:17582009
Haffner I et al. Regulation of arginase-1 expression in macrophages by a protein kinase A type I and histone deacetylase dependent pathway. 2008 J. Cell. Biochem. pmid:17577214
Kitamura H et al. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition. 2007 J. Urol. pmid:17574613
Rigamonti D et al. Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators. 2007 J. Biol. Chem. pmid:17565993
Bai L and Merchant JL ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate. 2007 Biochem. Biophys. Res. Commun. pmid:17560543
Lin T et al. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. 2007 Surgery pmid:17560255
Smetana K et al. Effect of histone deacetylase inhibitors on the cell nucleus and nucleolus of leukemic myeloblasts in vitro - a cytochemical study. 2007 Acta Histochem. pmid:17559910
Donadelli M et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. 2007 Biochim. Biophys. Acta pmid:17555830
Khan Z et al. HDAC inhibition amplifies gap junction communication in neural progenitors: potential for cell-mediated enzyme prodrug therapy. 2007 Exp. Cell Res. pmid:17555745
Pinnoji RC et al. Repressor element-1 silencing transcription factor/neuronal restrictive silencer factor (REST/NRSF) can regulate HSV-1 immediate-early transcription via histone modification. 2007 Virol. J. pmid:17555596
Vecsey CG et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. 2007 J. Neurosci. pmid:17553985
Kaneko M et al. Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors. 2007 Int. Arch. Allergy Immunol. pmid:17541273
Fan J et al. [Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]. 2006 Zhonghua Zhong Liu Za Zhi pmid:17533736
Schwechter BR et al. Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. 2007 Invest. Ophthalmol. Vis. Sci. pmid:17525221
Wu J et al. Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. 2007 BMC Genomics pmid:17524140
Turaga RV et al. Werner syndrome protein prevents DNA breaks upon chromatin structure alteration. 2007 Aging Cell pmid:17521388
de Boer J et al. Inhibition of histone acetylation as a tool in bone tissue engineering. 2006 Tissue Eng. pmid:17518660
Royo H et al. Bsr, a nuclear-retained RNA with monoallelic expression. 2007 Mol. Biol. Cell pmid:17507654
Choy SW et al. C. elegans SIN-3 and its associated HDAC corepressor complex act as mediators of male sensory ray development. 2007 Biochem. Biophys. Res. Commun. pmid:17506990
Iliopoulos D et al. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. 2007 Ann. Rheum. Dis. pmid:17502362
Piotrowska H and Jagodzinski PP Trichostatin A, sodium butyrate, and 5-aza-2'-deoxycytidine alter the expression of glucocorticoid receptor alpha and beta isoforms in Hut-78 T- and Raji B-lymphoma cell lines. 2007 Biomed. Pharmacother. pmid:17498915
Hellebrekers DM et al. Identification of epigenetically silenced genes in tumor endothelial cells. 2007 Cancer Res. pmid:17483324
Gensert JM et al. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells. 2007 Neurobiol. Dis. pmid:17481908
Zhang C et al. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. 2007 J. Pathol. pmid:17471463
Vincent A et al. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. 2007 Oncogene pmid:17471237
Wong CM et al. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. 2007 Hepatology pmid:17464989
Yi T et al. Trichostatin A-mediated upregulation of p21(WAF1) contributes to osteoclast apoptosis. 2007 Exp. Mol. Med. pmid:17464183
[Isolation of drug-resistant mutant cells]. 1991 Tanpakushitsu Kakusan Koso pmid:1745788
Hwang CK et al. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. 2007 Mol. Cell. Biol. pmid:17452465
Higashi T et al. Histone H2A mobility is regulated by its tails and acetylation of core histone tails. 2007 Biochem. Biophys. Res. Commun. pmid:17445770
Cecconi D et al. Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 2007 Proteomics pmid:17443844
Hatjiharissi E et al. Proteomic analysis of waldenstrom macroglobulinemia. 2007 Cancer Res. pmid:17440091
De los Santos M et al. Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells. 2007 Mol. Cancer Ther. pmid:17431121
Liu T et al. Design and synthesis of a potent histone deacetylase inhibitor. 2007 J. Med. Chem. pmid:17419603
Chen Y et al. Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer. 2007 Int. J. Cancer pmid:17417779
Ryningen A et al. Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting. 2007 Leuk. Res. pmid:17416413
Horion J et al. Histone deacetylase inhibitor trichostatin A sustains sodium pervanadate-induced NF-kappaB activation by delaying IkappaBalpha mRNA resynthesis: comparison with tumor necrosis factor alpha. 2007 J. Biol. Chem. pmid:17409387
Snykers S et al. Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. 2007 BMC Dev. Biol. pmid:17407549
Seo H et al. An ex vivo method for rapid generation of monoclonal antibodies (ADLib system). 2006 Nat Protoc pmid:17406441
Cao D et al. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. 2007 Am. J. Respir. Cell Mol. Biol. pmid:17395887
Dompierre JP et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. 2007 J. Neurosci. pmid:17392473
Rohner A et al. Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. 2007 Leuk. Res. pmid:17391757
Vandergeeten C et al. HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA. 2007 Biochem. Pharmacol. pmid:17386923
Wu Y and Guo SW Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. 2008 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:17376583
Hummel M et al. Transcriptional reactivation of murine cytomegalovirus ie gene expression by 5-aza-2'-deoxycytidine and trichostatin A in latently infected cells despite lack of methylation of the major immediate-early promoter. 2007 J. Gen. Virol. pmid:17374752
Kim HJ et al. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. 2007 J. Pharmacol. Exp. Ther. pmid:17371805
Hosseinkhani M et al. Trichostatin A induces myocardial differentiation of monkey ES cells. 2007 Biochem. Biophys. Res. Commun. pmid:17368572
Hashii M et al. Up-regulation of ras-GAP genes is reversed by a MEK inhibitor and doxorubicin in v-Ki-ras-transformed NIH/3T3 fibroblasts. 2007 Biochem. Biophys. Res. Commun. pmid:17367762
Li B et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:17360565
Barr H et al. Mbd2 contributes to DNA methylation-directed repression of the Xist gene. 2007 Mol. Cell. Biol. pmid:17353271
Hattori N et al. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. 2007 Genes Cells pmid:17352742
Krennhrubec K et al. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17346959
Vikhanskaya F et al. Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53. 2007 Nucleic Acids Res. pmid:17344317
Alimirah F et al. IFI16 in human prostate cancer. 2007 Mol. Cancer Res. pmid:17339605
Jaffe RC et al. Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression. 2007 J. Mol. Endocrinol. pmid:17339403
Jung J and Bonini N CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. 2007 Science pmid:17332375
Stiehl DP et al. Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. 2007 Cancer Res. pmid:17332356
Pan L et al. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. 2007 Cancer pmid:17330857
Vibhakar R et al. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma. 2007 Neuro-oncology pmid:17329407
Putignano E et al. Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity. 2007 Neuron pmid:17329213
Xin C et al. FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism. 2007 Br. J. Pharmacol. pmid:17325654
Di Renzo F et al. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity. 2007 Toxicol. Appl. Pharmacol. pmid:17320131
Avila AM et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. 2007 J. Clin. Invest. pmid:17318264
Sugita K et al. A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene. 1992 Biochem. Biophys. Res. Commun. pmid:1731795
Mayo C et al. In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression. 2007 J. Cell. Physiol. pmid:17311291
Yang QC et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. 2006 J. Exp. Clin. Cancer Res. pmid:17310851
Bui HT et al. Regulation of chromatin and chromosome morphology by histone H3 modifications in pig oocytes. 2007 Reproduction pmid:17307905
Appanah R et al. An unmethylated 3' promoter-proximal region is required for efficient transcription initiation. 2007 PLoS Genet. pmid:17305432
Wu Y and Guo SW Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. 2007 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:17296257
Ou JN et al. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. 2007 Biochem. Pharmacol. pmid:17276411